Pål Aukrust to Acute Coronary Syndrome
This is a "connection" page, showing publications Pål Aukrust has written about Acute Coronary Syndrome.
Connection Strength
0.385
-
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2019 08 13; 74(6):774-782.
Score: 0.074
-
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial. Eur Heart J Acute Cardiovasc Care. 2020 Jun; 9(4):313-322.
Score: 0.073
-
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol. 2019 02; 39(2):294-302.
Score: 0.071
-
Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome. Int J Cardiol. 2018 07 01; 262:79-84.
Score: 0.067
-
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. J Am Heart Assoc. 2018 01 12; 7(2).
Score: 0.066
-
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol. 2008 Feb 12; 51(6):627-33.
Score: 0.033